MyFinsight
Home
Blog
About
Restricted cash
$3,800,003
Cash
$1,739,943
(-3.79%↓ Y/Y)
Prepaid expenses
$47,064
(6.22%↑ Y/Y)
Total current assets
$5,587,010
(201.53%↑ Y/Y)
Digital assets
$1,904,954
Right of use assets
$400,717
(-22.93%↓ Y/Y)
Fixed assets, net
$43,538
(-31.35%↓ Y/Y)
Other assets
$5,986
(0.00%↑ Y/Y)
Total assets
$7,942,205
(182.88%↑ Y/Y)
Total liabilities and
stockholders equity
$7,942,205
(182.88%↑ Y/Y)
Total stockholders
equity
$6,309,691
(328.31%↑ Y/Y)
Total liabilities
$1,632,514
(22.33%↑ Y/Y)
Accumulated deficit
-$111,616,998
(-5.60%↓ Y/Y)
Receivable related to
employee equity awards
-$72,981
Additional paid in capital
$117,999,522
(10.10%↑ Y/Y)
Total long term debt
$845,936
(11.62%↑ Y/Y)
Total current
liabilities
$786,578
(36.41%↑ Y/Y)
Common stock, 0.0001
par value...
$148
(100.00%↑ Y/Y)
Warrant liability
$555,306
(68.99%↑ Y/Y)
Lease liabilities
$290,630
(-32.30%↓ Y/Y)
Accounts payable and
accrued liabilities
$647,934
(44.49%↑ Y/Y)
Lease liabilities,
current portion
$138,644
(8.13%↑ Y/Y)
Back
Back
Balance Sheet
ENDRA Life Sciences Inc. (NDRA)
ENDRA Life Sciences Inc. (NDRA)
source: myfinsight.com